A randomised trial of non-mydriatic ultra-wide field retinal imaging versus usual care to screen for diabetic eye disease: rationale and protocol for the Clearsight trial

INTRODUCTION: Suboptimal screening for diabetic eye disease is a major cause of preventable vision loss. Screening barriers include mydriasis and the extra time patients need to attend dedicated eye screening appointments. In the Clearsight trial, we are testing whether screening by non-mydriatic ul...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Selina L, Mahon, Lewis W, Klar, Neil S, Schulz, David C, Gonder, John R, Hramiak, Irene M, Mahon, Jeffrey L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724207/
https://www.ncbi.nlm.nih.gov/pubmed/28775182
http://dx.doi.org/10.1136/bmjopen-2016-015382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724207/
https://www.ncbi.nlm.nih.gov/pubmed/28775182
http://dx.doi.org/10.1136/bmjopen-2016-015382

Ejemplares similares